mWELLCARE:An Integrated mHealth System for the Prevention and Care of Chronic Disease

NCT ID: NCT02480062

Last Updated: 2017-10-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

3702 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-04-30

Study Completion Date

2017-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Major barriers to controlling cardiovascular diseases (CVDs) in India and elsewhere are: low detection rates, inadequate use of evidence based interventions and low adherence with these interventions. Primary health care is the appropriate setting for improving the prevention and management of these chronic conditions. The investigators will develop and evaluate an innovative mobile health (mHealth) software application -'m-WELLCARE'- which provides a patient health profile, decision support for clinical care, monitoring and feedback for use in Indian Community Health Centers (CHCs). The investigators will conduct this research following the steps proposed by the medical research council (MRC) for evaluation of complex interventions. Technical development of m-WELLCARE will be conducted, user acceptability appraised and potential barriers overcome. m-WELLCARE will be evaluated in CHCs of two states, Haryana and Karnataka. The use made of m-WELLCARE, its impact on patterns of health care received and changes in risk factors achieved will be evaluated.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cardiovascular disease (CVD) and diabetes are the leading causes of premature (\<60 years) adult deaths in India with projections indicating an almost 3-fold increase to 18 million premature years of life lost by 2030. CVD and diabetes will result in $336.6 billion in lost national income in India over the next decade. The major barriers to the control of these conditions in India are the low detection rates early in the course of the condition, inadequate use of evidence based interventions and low adherence with these interventions. After detection of these conditions, the long-term health outcomes of persons affected is heavily dependent on adherence with care guidelines and is a major priority.

Harnessing the potential of Smartphone technology would be a solution for addressing these challenges at the community level by improving the quality of care. There are several advantages for Smartphone technology that makes it an ideal tool for improving the quality care at the government facilities. Smartphones/tablet computers are low-cost, requires less investment in infrastructure and are ubiquitous used by the masses.

Primary health care settings are best suited to address the prevention and management of hypertension/diabetes and its risk factors. Given these reasons, the Government of India, is planning to scale-up the National Program on prevention and control of cancer, diabetes, cardiovascular diseases and stroke (NPCDCS) giving a major thrust to screening, diagnosis and management of hypertension and diabetes at community level by starting NCD clinics at the Community Health Centres and assigning new roles to the Health Workers at the sub-centers.

In the above context, the investigators plan to develop a tablet computer application for the Medical Officers and Nurse enabling them to deliver high quality care at Community Health Centres (CHCs). The tablet computer application will be capable of running clinical risk scores for identifying people at high risk of diabetes, cardiovascular disease, and computing personalized management plan using evidence-based clinical management guidelines. The feasibility and effectiveness of such a novel application is to be formally evaluated in order to develop a robust clinical decision support system for the Nurses and Medical Officers at the public health facilities.

In brief, the investigators plan to implement the research project in the 20 CHCs each in 2 states in India i.e.Haryana and Karnataka. Out of these, 10 CHCs will receive the mWellcare interventions. In the intervention arm, the NPCDCS Nurses will register 30 years+ patient diagnosed with hypertension and diabetes using tablet computer based Decision Support Software (DSS). For the patients identified with hypertension/diabetes or at high risk, the software will provide individual tailored management plan that would include treatment plan, lifestyle advice and follow up schedule. Thus, Medical Officers at CHCs will be able to prescribe a guideline based management plan for these patients with the help of DSS. The software will store relevant health parameters of patients at local database (tablet computer) and central server that could be accessed during the follow-up visits of the patients or whenever required.

To make meaningful comparison on the impact of the new technology enabled services in improving the quality of care of diabetes and hypertension at the CHCs, the investigators will collect data from 10 more CHCs that provide routine/usual care to the patients. A structured training will be conducted for Medical Officers and Nurse at CHCs (both from the intervention \& usual care arm) on evidence based management of hypertension and diabetes prior to the start of the project.

The intervention will be carried out for a period of 1 year that would include regular follow up. The effect of the intervention will be assessed at six and twelve month comparing the blood pressure and blood glucose values of the patients in two groups.

This project has considerable importance because of the fact that the utility of tablet computer based clinical decision support systems in the management of hypertension and diabetes at the public health facilities has not been evaluated in developing countries so far. If found successful, the technology has the potential to be upscale not only in Haryana and Karnataka but across the country in government and private healthcare settings.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension Diabetes Depression Alcohol Use Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

mWELLCARE software arm

The doctor and nurse care coordinators (NCCs) in the mWELLCARE intervention arm will be trained on the use of mWELLCARE software loaded on a tablet computer. Patients diagnosed with hypertension and/or diabetes will be registered by the nurse using mWellcare application. The nurse will record patient parameters, medical history, medication etc and generate a management plan (including drug recommendation, lifestyle advise) using the mWellcare application based on standard treatment guidelines. The doctor will review the recommendation and agree or disagree giving reasons. Patient will be followed up using SMS.

Group Type EXPERIMENTAL

mWELLCARE

Intervention Type OTHER

mWELLCARE intervention arm will include a software application loaded on a tablet computer that will be used by Nurse Care Coordinators (posted in community health centers) in the course of their jobs to register patients with hypertension or diabetes, to generate clinical decision support recommendations, to track these patients over time and to improve follow-up care. Decision support recommendations will be printed and given to a doctor, who will make the final call on the management plan that will be used for the patient. Registered patients will also receive customized messages on their mobile phone. In addition, at sites where network connectivity permits, the doctor may also be equipped with a doctor's app on a tablet that will be largely the same as the NCC app.

Usual care arm

In the control arm or the usual care arm CHCs, the doctor and Nurse will get "refresher" training in the detection, management and follow up of hypertension and diabetes patients based on standard guidelines. They will be provided with charts for quick reference to standard treatment guidelines. Patients diagnosed with hypertension and/or diabetes will be managed by the doctor at the CHC. The nurse will assist in recording blood pressure, height, weight etc, providing lifestyle advise and follow up advice to patients.

Group Type ACTIVE_COMPARATOR

Usual Care

Intervention Type OTHER

Usual care at the community health centers

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

mWELLCARE

mWELLCARE intervention arm will include a software application loaded on a tablet computer that will be used by Nurse Care Coordinators (posted in community health centers) in the course of their jobs to register patients with hypertension or diabetes, to generate clinical decision support recommendations, to track these patients over time and to improve follow-up care. Decision support recommendations will be printed and given to a doctor, who will make the final call on the management plan that will be used for the patient. Registered patients will also receive customized messages on their mobile phone. In addition, at sites where network connectivity permits, the doctor may also be equipped with a doctor's app on a tablet that will be largely the same as the NCC app.

Intervention Type OTHER

Usual Care

Usual care at the community health centers

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Software application loaded on a tablet computer

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults aged 30 yrs+ diagnosed with hypertension and /or diabetes who are able to give written consent (or verbal witnessed consent for illiterate patients).

Exclusion Criteria

1. Patient requiring immediate referral to tertiary care due to accelerated hypertension, diabetic complications.
2. Patients with learning difficulties or vision/ hearing impairments but without a care giver making it impossible to use mobile phone.
3. Pregnant and lactating women.
Minimum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Wellcome Trust

OTHER

Sponsor Role collaborator

London School of Hygiene and Tropical Medicine

OTHER

Sponsor Role collaborator

Public Health Foundation of India

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dorairaj Prabhakaran

Role: PRINCIPAL_INVESTIGATOR

Public Health Foundation of India

Vikram Patel

Role: PRINCIPAL_INVESTIGATOR

London School of Hygeine and Tropical Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHC Assandh

Āsandh, Haryana, India

Site Status

CHC Ballah

Ballah, Haryana, India

Site Status

CHC Brara

Brara, Haryana, India

Site Status

CHC Chauramastpur

Chauramastpur, Haryana, India

Site Status

CHC Gharaunda

Gharaunda, Haryana, India

Site Status

CHC Indri

Indri, Haryana, India

Site Status

CHC Jhansa

Jhānsa, Haryana, India

Site Status

CHC Ladwa

Lādwa, Haryana, India

Site Status

CHC Mathana

Mathāna, Haryana, India

Site Status

CHC Mullana

Mullana, Haryana, India

Site Status

CHC Mustafabad

Mustafābād, Haryana, India

Site Status

CHC Naharpur

Nāharpur, Haryana, India

Site Status

CHC Nilokheri

Nīlokheri, Haryana, India

Site Status

CHC Nissing

Nīsang, Haryana, India

Site Status

CHC Pehowa

Pehowa, Haryana, India

Site Status

CHC Radaur

Radaur, Haryana, India

Site Status

CHC Sadhaura

Sādhaura, Haryana, India

Site Status

CHC Shahzadpur

Shahzādpur, Haryana, India

Site Status

CHC Shahbad

Shāhābād, Haryana, India

Site Status

CHC Taraori

Tirāwari, Haryana, India

Site Status

CHC Anandapuram

Anantapur, Karnataka, India

Site Status

CHC Aynur

Aynur, Karnataka, India

Site Status

CHC Anavatti

Ānavatti, Karnataka, India

Site Status

Taluk Hospital Bhadravathi

Bhadravathi, Karnataka, India

Site Status

CHC CN Halli

CN Halli, Karnataka, India

Site Status

CHC Gubbi

Gubbi, Karnataka, India

Site Status

CHC Holehonnuru

Holehonnuru, Karnataka, India

Site Status

Taluk Hospital Hosanagara

Hosanagara, Karnataka, India

Site Status

CHC Kannangi

Kannangi, Karnataka, India

Site Status

General Hospital Koratagere

Koratagere, Karnataka, India

Site Status

General Hospital Kunigal

Kunigal, Karnataka, India

Site Status

CHC M.N.Kote

M.N.Kote, Karnataka, India

Site Status

General Hospital Madhugiri

Madhugiri, Karnataka, India

Site Status

General Hospital Pavagada

Pāvugada, Karnataka, India

Site Status

Taluk Hospital Sagar

Sāgar, Karnataka, India

Site Status

CHC Shiralkoppa

Shiralkoppa, Karnataka, India

Site Status

General Hospital Sira

Sīra, Karnataka, India

Site Status

CHC Kannangi

Thirthahalli, Karnataka, India

Site Status

General Hospital Tiptur

Tiptūr, Karnataka, India

Site Status

CHC Turuvekere

Turuvekere, Karnataka, India

Site Status

Countries

Review the countries where the study has at least one active or historical site.

India

References

Explore related publications, articles, or registry entries linked to this study.

Krishna S, Boren SA, Balas EA. Healthcare via cell phones: a systematic review. Telemed J E Health. 2009 Apr;15(3):231-40. doi: 10.1089/tmj.2008.0099.

Reference Type BACKGROUND
PMID: 19382860 (View on PubMed)

D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008 Feb 12;117(6):743-53. doi: 10.1161/CIRCULATIONAHA.107.699579. Epub 2008 Jan 22.

Reference Type BACKGROUND
PMID: 18212285 (View on PubMed)

Chalkidou K, Levine R, Dillon A. Helping poorer countries make locally informed health decisions. BMJ. 2010 Jul 16;341:c3651. doi: 10.1136/bmj.c3651. No abstract available.

Reference Type BACKGROUND
PMID: 20639295 (View on PubMed)

Wee HL, Loke WC, Li SC, Fong KY, Cheung YB, Machin D, Luo N, Thumboo J. Cross-cultural adaptation and validation of Singapore Malay and Tamil versions of the EQ-5D. Ann Acad Med Singap. 2007 Jun;36(6):403-8.

Reference Type BACKGROUND
PMID: 17597964 (View on PubMed)

Prabhakaran D, Jha D, Prieto-Merino D, Roy A, Singh K, Ajay VS, Jindal D, Gupta P, Kondal D, Goenka S, Jacob P, Singh R, Kumar BGP, Perel P, Tandon N, Patel V; Members of the Research Steering Committee,Investigators,Members of the Data Safety and Monitoring Board. Effectiveness of an mHealth-Based Electronic Decision Support System for Integrated Management of Chronic Conditions in Primary Care: The mWellcare Cluster-Randomized Controlled Trial. Circulation. 2019 Jan 15;139(3):380-391. doi: 10.1161/CIRCULATIONAHA.118.038192. Epub 2018 Nov 10.

Reference Type DERIVED
PMID: 30586732 (View on PubMed)

Jindal D, Gupta P, Jha D, Ajay VS, Goenka S, Jacob P, Mehrotra K, Perel P, Nyong J, Roy A, Tandon N, Prabhakaran D, Patel V. Development of mWellcare: an mHealth intervention for integrated management of hypertension and diabetes in low-resource settings. Glob Health Action. 2018;11(1):1517930. doi: 10.1080/16549716.2018.1517930.

Reference Type DERIVED
PMID: 30253691 (View on PubMed)

Jha D, Gupta P, Ajay VS, Jindal D, Perel P, Prieto-Merino D, Jacob P, Nyong J, Venugopal V, Singh K, Goenka S, Roy A, Tandon N, Patel V, Prabhakaran D. Protocol for the mWellcare trial: a multicentre, cluster randomised, 12-month, controlled trial to compare the effectiveness of mWellcare, an mHealth system for an integrated management of patients with hypertension and diabetes, versus enhanced usual care in India. BMJ Open. 2017 Aug 11;7(8):e014851. doi: 10.1136/bmjopen-2016-014851.

Reference Type DERIVED
PMID: 28801393 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://faculty.washington.edu/wcurioso/curioso_ch18.pdf

Curioso, W., New technologies and public health in developing countries: the Cell PREVEN project, in The Internet and health care: theory, research and practice, M. Murero and R. Rice, Editors. 2006, Lawrence Erlbaum Associates: Mahwah (NJ).

http://faculty.washington.edu/wcurioso/Curioso_HealthAffairs.pdf

Curioso, W. and P. Mechael, Enhancing 'M-Health' With South-To-South Collaborations. Health Affairs, 2010(29): p. 264-267.

http://unpan1.un.org/intradoc/groups/public/documents/unpan/unpan037268.pdf

Vital Wave Consulting, mHealth for Development: The Opportunity of Mobile Technology for Healthcare in the Developing World. . 2009, UN Foundation-Vodafone Foundation Partnership: Washington, D.C. and Berkshire, UK.

http://econpapers.repec.org/article/wlyjintdv/v_3a15_3ay_3a2003_3ai_3a1_3ap_3a1-14.htm

Hanson, K., et al., Expanding access to priority health interventions: a framework for understanding the constraints to scaling-up. J of International Development, 2003. 15(1): p. 1-14.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1524730/

Kaplan, W., Can the ubiquitous power of mobile phones be used to improve health outcomes in developing countries? . Global Health, 2006(2): p. 9.

http://www.bmj.com/content/324/7328/47.2

Rigby, M., Impact of telemedicine must be defined in developing countries. bmj, 2002. 324(7328): p. 47.

http://www.whoindia.org/LinkFiles/

http://www.whoindia.org/LinkFiles/NMH\_Resources\_CVD\_RISK\_MANAGEMENT\_BOOKLET.pdf

http://whqlibdoc.who.int/publications/2010/9789241548069_eng.pdf

mhGAP Intervention Guide for mental, neurological and substance use disorders in non-specialist health settings. ver 1.0. World Health Organisation Geneva, 2010.

http://www.biomedcentral.com/1756-0500/3/250

Free C, Phillips G, Watson L, Gallo L, Lambert F, Patel V, Edwards P. The Effectiveness Of Mobile Health Technologies for Improving Health and Health Services: A Systematic Review. Report for Department of Health, England (in preparation)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

mWELLCARE 107/11

Identifier Type: -

Identifier Source: org_study_id